Bariatrics
Authors:
M. Fried
Authors place of work:
OB klinika – Centrum pro léčbu obezity a metabolických onemocnění, Praha
; 1. lékařská fakulta UK v Praze
Published in the journal:
Gastroent Hepatol 2016; 70(6): 472
Category:
Editorial
Zdroje
1. Holéczy P, Bužga M. Současná bariatricko- metabolická chirurgie. Gastroent Hepatol 2016; 70(6): 485– 490. doi: 10.14735/amgh2016485.
2. Beneš M, Hucl T, Drastich P et al. Endoskopický duodenojejunální bypass (EndoBarrier®) jako nový terapeutický přístup u obézních diabetiků 2. typu – efektivita a faktory predikující optimální efekt. Gastroent Hepatol 2016; 70(6): 491-499. doi: 10.14735/amgh2016491.
Štítky
Paediatric gastroenterology Gastroenterology and hepatology SurgeryČlánok vyšiel v časopise
Gastroenterology and Hepatology
2016 Číslo 6
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
- Current Insights into the Antispasmodic and Analgesic Effects of Metamizole on the Gastrointestinal Tract
- Obstacle Called Vasospasm: Which Solution Is Most Effective in Microsurgery and How to Pharmacologically Assist It?
Najčítanejšie v tomto čísle
- Importance of faecal calprotectin in screening and clinical assessment of adult and pediatric patients with inflammatory bowel diseases
- Budesonide MMX (Cortiment® 9 mg) in the treatment of ulcerative colitis in real clinical practice
- Czech Society of Gastroenterology guidelines for diagnostic and therapeutic colonoscopy
- The duodenal-jejunal bypass liner (EndoBarrier®) for the treatment of type 2 diabetes mellitus in obese patients – efficacy and factors predicting optimal effects